Thermoresponsive Polymer Colloids for Drug Delivery and Cancer Therapy
โ Scribed by Samer R. Abulateefeh; Sebastian G. Spain; Jonathan W. Aylott; Weng C. Chan; Martin C. Garnett; Cameron Alexander
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 738 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1616-5187
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Many difficulties in treating cancer arise from the problems in directing highly cytotoxic agents to the deseased tissues, cells and intracellular compartments. Many drug delivery systems have been devised to address this problem, including those that show a change in properties in response to a temperature stimulus. In particular, colloidal materials based on thermoresponsive polymers offer a means to transport drugs selectively into tumour tissues that are hyperthermic, either intrinsically or through the application of clinical procedures such as localised heating. In this paper, the key attributes of thermoresponsive polymer colloids are considered, a number of important recent examples are discussed and the possible future developments of these materials are evaluated.magnified image
๐ SIMILAR VOLUMES
## Abstract Novel polymer micelles, prepared by selfโassembling thermoresponsive poly(__N__โisopropylacrylamide)__โgraftโ__poly[__N__โ(2โhydroxypropyl)methacrylamide] copolymers with hydrolytically degradable __N__โglycosylamine groups between the polymer blocks are proposed for delivery of diagnos
The use of nanoparticles and ultrasound in medicine continues to evolve. Great strides have been made in the areas of producing micelles, nanoemulsions, and solid nanoparticles that can be used in drug delivery. An effective nanocarrier allows for the delivery of a high concentration of potent medic
Liposomal locked-in dendrimers (LLDs), the combination of liposomes and dendrimers in one formulation, represents a relatively new term in the drug carrier technology. LLDs undergone appropriate physicochemical investigation can merge the benefits of liposomal and dendrimeric nanocarriers. In this s